by The Economist
My articles My siteMy videosMy books
Follow on:LinkedINTwitterFacebookYoutubeAmazonGoogle +
| A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Now & Next is a series from The Economist Films: https://films.economist.com/nowandnext/ Further content: Find The Economist’s most recent coverage of covid-19 here: https://econ.st/3iwmMMH Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 analysis: https://econ.st/2Ckne0X The immense promise of the new covid-19 vaccine, and the challenges still to come: https://econ.st/36EgZAd Why an effective covid-19 vaccine is a turning point in the pandemic: https://econ.st/3kJfJRr Read more about Pfizer’s and BioNTech’s vaccine: https://econ.st/3pyBvem A second, better, vaccine against covid-19 arrives—read about Moderna’s vaccine: https://econ.st/3kEfOpE Rich countries have grabbed half of projected covid-19 vaccine supply: https://econ.st/3nveNSm Daily chart: One in three people want preferential access to a covid-19 vaccine: https://econ.st/2IyoYah How pandemic fears are boosting demand for trustworthy news: https://econ.st/2UzCMU7 Super fast tests for covid-19 are coming: https://econ.st/32S1Ie5 How the quest for a vaccine could restore faith in big pharma: https://econ.st/32RSRJn |
The Economist offers authoritative insight and opinion on international news, politics, business, finance, science, technology and the connections between them.
Tags:
